newsfilter
← Latest News
PR Newswire·

Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution

DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first generic version of Merz's CUVPOSA® (glycopyrrolate) 1 mg/5 mL ora